🇺🇸 FDA
Patent

US 6600030

Delayed progression to aids by a missense allele of the CCR2 gene

expired A61KA61K38/00A61K48/00

Quick answer

US patent 6600030 (Delayed progression to aids by a missense allele of the CCR2 gene) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61K48/00, A61P, A61P11/00